Developing next-generation T-cell therapies for patients with solid tumors.
| Title |
|---|
| Sr. Specialist, Electronic Quality Management Systems (eQMS) Full Time · $124K-$155K · 10+ YOE Bothell, Washington, United States · Onsite |
| Program Manager II - Contract role Full Time · 7+ YOE Bothell or South San Francisco or Seattle · Hybrid |
| Manager, Supplier and Vendor Audit Program Full Time · $124K-$150K · 12+ YOE Bothell, Washington, United States · Onsite |
| Senior Associate, Quality Assurance Full Time · $75K-$95K · 4+ YOE Bothell, Washington, United States · Onsite |
| Manager, Quality Control Full Time · 8+ YOE Bothell, Washington, United States · Onsite |
| Director, MSAT Full Time · $195K-$240K · 15+ YOE Bothell, Washington, United States · Onsite |
| Activities | cell therapy developmentcancer immunotherapyCAR T-cell engineeringclinical drug manufacturingT-cell reprogramming |
| Headquarters | US |
| Industries | BiotechnologyOncology |
| Name | Lyell Immunopharma |
| Employees | 300 |
| Type | Public |
| Tagline | Developing next-generation T-cell therapies for patients with solid tumors. |
| Founded | 2,018 |
| Website | lyell.com |
| Stock Exchange | NASDAQ |
| Stock Symbol | LYEL |